Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP412117.RAm3e8nDcPgjbedPf3I50j4_fMj7qegOoXiXyzEJ7Mzfc130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412117.RAm3e8nDcPgjbedPf3I50j4_fMj7qegOoXiXyzEJ7Mzfc130_provenance.
• NP440595.RAugf1lG_PIhRYr8nJ0U8NwnmAU1TNcte4rGLRi_qjyYo130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440595.RAugf1lG_PIhRYr8nJ0U8NwnmAU1TNcte4rGLRi_qjyYo130_provenance.
• NP375827.RAEL41xpK5_KbMrY3AvLnTG6n0fNe4ID0d4K08YypdxSE130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375827.RAEL41xpK5_KbMrY3AvLnTG6n0fNe4ID0d4K08YypdxSE130_provenance.
• NP731208.RA6zo5kcTSSn_Wed5yIRIdWbPOkJLcSYdlzLzIlhzynHE130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731208.RA6zo5kcTSSn_Wed5yIRIdWbPOkJLcSYdlzLzIlhzynHE130_provenance.
• NP747583.RAYKTRJlnRsixOhoGqli4GUWQ8XeOM5z9xaTvvpM5WriU130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747583.RAYKTRJlnRsixOhoGqli4GUWQ8XeOM5z9xaTvvpM5WriU130_provenance.
• NP863091.RATWXsJrMW5oa5Gxv8zmso0t0QBZ-X1tO83u09W5-1pK0130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863091.RATWXsJrMW5oa5Gxv8zmso0t0QBZ-X1tO83u09W5-1pK0130_provenance.
• NP505369.RAucp1gtHCH_AhQZ651IUHf3l3_RbdNL9DXzq1vVJGlZs130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505369.RAucp1gtHCH_AhQZ651IUHf3l3_RbdNL9DXzq1vVJGlZs130_provenance.
• NP863092.RAAqENjgsxLvEY8cxDbWAKTnDb8JBnGPzgH105E4kb5YI130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863092.RAAqENjgsxLvEY8cxDbWAKTnDb8JBnGPzgH105E4kb5YI130_provenance.
• NP863095.RAAUDaksV9g2JIZMxDbOQMKvGuPpZSc6LiNggTaNCPyLI130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863095.RAAUDaksV9g2JIZMxDbOQMKvGuPpZSc6LiNggTaNCPyLI130_provenance.
• NP863090.RAlJJI1m0FBAhdYUgkLxAHcCK_zKdivq9khcQSVgBQ9ec130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863090.RAlJJI1m0FBAhdYUgkLxAHcCK_zKdivq9khcQSVgBQ9ec130_provenance.
• NP863094.RAp0DbjuEc9Tu_tgAlAnDAEwjtEoG1CuIBRr-FnU0Oc3E130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863094.RAp0DbjuEc9Tu_tgAlAnDAEwjtEoG1CuIBRr-FnU0Oc3E130_provenance.
• NP499819.RA_od6onSdHYXYF48mMLnAY60_MutE5qnwsGOIBBirWr8130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499819.RA_od6onSdHYXYF48mMLnAY60_MutE5qnwsGOIBBirWr8130_provenance.
• NP505342.RAzcBjpqloee9avIVEne7N1ua25xdZ17QIFVV4J6AGsv0130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505342.RAzcBjpqloee9avIVEne7N1ua25xdZ17QIFVV4J6AGsv0130_provenance.
• NP747625.RAGKG1jATeYTK-mDgIvyARrf5NDlewMZ7InKFmc3JkpDk130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747625.RAGKG1jATeYTK-mDgIvyARrf5NDlewMZ7InKFmc3JkpDk130_provenance.
• NP499849.RAPab_zKEGiQHEQZcU1eiOJaX2FgwQWbiRS_POo5TIFYs130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499849.RAPab_zKEGiQHEQZcU1eiOJaX2FgwQWbiRS_POo5TIFYs130_provenance.
• NP863093.RA6p1fGurvP7D86oq8jW_FXnT1lG7borHheLPLJcCbgMY130_assertion description "[Systemic onset JIA (SoJIA) accounts for approximately 5.8% of all JIA cases and is associated with cytokine dysregulation, including interleukin (IL-)1, IL-6 and tumour necrosis factor (TNF-)?. IL-10 is an immuno-regulatory cytokine, which in part regulates inflammation by controlling inflammatory cytokine expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863093.RA6p1fGurvP7D86oq8jW_FXnT1lG7borHheLPLJcCbgMY130_provenance.